Clinical Trial Update: Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating low-dose interval radiotherapy combined with Tirelizumab and SOX chemotherapy for locally advanced gastric/gastroesophage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Tirelizumab (tirelizumab)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING